Entity
-
Wacker Biotech B.V.
- Chemicals
- Paasheuvelweg 30
- 1105 BJ
-
With the takeover of SynCo Bio Partners B.V. in Amsterdam, the Netherlands, in 2018 Wacker Chemie AG strengthened its pharmaceutical protein business and expanded its portfolio – an important step to keep pace with the rapidly growing biologics market. Following the acquisition in April last year, the new name Wacker Biotech B.V. came into effect in November. Just like Wacker Biotech GmbH, Wacker Biotech B.V. is a full-service contract manufacturer of biopharmaceutical proteins based on microbial systems. The new Amsterdam site joins Jena and Halle as Wacker Biotech’s third state-of-the-art production site that guarantees top quality standards in accordance with GMP (good manufacturing practice).
Entity Settings
- Category
- Main Holding Company or Operations
- Status
- A
- V
- P
- Lg
- Sh
System Info
- Modified by
-  Braun, Uwe
- Modified
- 11/1/2022 2:03 PM
- Added by
-  Braun, Uwe
- Added
- 11/1/2022 1:10 PM
No Services yet available.
Enquire in Solutions how we can help you.
  Entity Communicator  (including Site Messages)
Site | Title | Date |
---|
  Sites Quick Access
Site | Location | Country |
---|---|---|
Wacker Amsterdam | Amsterdam |
|
Featured Function
Interests Map | View the Operations, Shareholding, and Subsidiaries of this Entity |